Shell Asset Management CO Invitae Corp Transaction History

Shell Asset Management CO

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$1.2 - $2.73 $23,425 - $53,292	19,521 Added 379.64%	24,663 $33,000
Q4 2022 Feb 07, 2023	SELL	$1.71 - $3.61 $1,610 - $3,400	-942 Reduced 15.48%	5,142 $10,000
Q3 2022 Nov 14, 2022	SELL	$1.9 - $8.63 $1,043 - $4,737	-549 Reduced 8.28%	6,084 $15,000
Q2 2022 Aug 09, 2022	BUY	$2.13 - $9.01 $308 - $1,306	145 Added 2.23%	6,633 $16,000
Q1 2022 May 04, 2022	SELL	$6.28 - $15.59 $5,978 - $14,841	-952 Reduced 12.8%	6,488 $52,000

Q4 2021 Feb 09, 2022	BUY	$14.7 - $28.67 $2,719 - $5,303	185 Added 2.55%	7,440 $114,000
Q3 2021 Nov 04, 2021	SELL	$24.31 - $33.6 $7,536 - $10,416	-310 Reduced 4.1%	7,255 $206,000
Q2 2021 Aug 12, 2021	BUY	$26.09 - $40.4 $10,696 - $16,564	410 Added 5.73%	7,565 $255,000
Q1 2021 May 10, 2021	BUY	$33.06 - $56.93 $236,544 - $407,334	7,155 New	7,155 $273,000

7.66M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Shell Asset Management CO, based on Form 13F filings with the SEC.

Stay updated on Shell Asset Management CO with notifications on news.